Cargando…

Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity

Detalles Bibliográficos
Autor principal:	Obi, Ogugua Ndili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819261/ https://www.ncbi.nlm.nih.gov/pubmed/36584989 http://dx.doi.org/10.1513/AnnalsATS.202208-731ED

Ejemplares similares

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
por: Obi, Ogugua Ndili, et al.
Publicado: (2022)

Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023)

HISTOPLASMOSIS IN PATIENT WITH SARCOIDOSIS
por: Wooten, William, et al.
Publicado: (2020)

Acute motor neuropathy with quadriparesis following treatment with triple tyrosine kinase inhibitor, nintedanib
por: Kunadu, Afua, et al.
Publicado: (2021)

The prognostic value of gastroesophageal reflux disorder in interstitial lung disease related hospitalizations
por: Alqalyoobi, Shehabaldin, et al.
Publicado: (2023)

The Production of Vital Force
Publicado: (1849)

Difference between slow vital capacity and forced vital capacity in the diagnosis of airflow limitation
por: Pereira, Carlos Alberto de Castro
Publicado: (2020)

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
por: Santermans, Eva, et al.
Publicado: (2019)

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern
por: Khalid, Imran, et al.
Publicado: (2011)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
por: Zhang, Xiaoling, et al.
Publicado: (2020)

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis
por: Lassenius, Mariann I., et al.
Publicado: (2019)

Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease
por: Moon, Seong Mi, et al.
Publicado: (2021)

Vitality and the Vital Forces
por: Noel, H. R.
Publicado: (1870)

Arsenate DNA—Evidence for a Vital Force?
por: Schwartz, Alan W.
Publicado: (2010)

Association of Forced Vital Capacity with the Developmental Gene NCOR2
por: Minelli, Cosetta, et al.
Publicado: (2016)

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
por: Reichmann, William M., et al.
Publicado: (2015)

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020)

Obesity and Weaning from Mechanical Ventilation—An Exploratory Study
por: Obi, Ogugua Ndili, et al.
Publicado: (2018)

Quantification of Reduction in Forced Vital Capacity of Sand Stone Quarry Workers
por: Singh, Suresh Kumar, et al.
Publicado: (2007)

Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma
por: Lutfi, Mohamed Faisal
Publicado: (2011)

Effects of pelvic tilt angles and forced vital capacity in healthy individuals
por: Hwang, Young-In, et al.
Publicado: (2018)

Correlation between Forced Vital Capacity and the Severity of Frailty-Induced Dysphagia
por: Lee, Byung Joo, et al.
Publicado: (2022)

Predicted values for the forced expiratory flow adjusted for forced vital capacity, a descriptive study
por: Cox, Claire A., et al.
Publicado: (2020)

Vital Force
por: Watt, Geo.
Publicado: (1873)

Vital Force
por: Shank, A. R.
Publicado: (1878)

Vital Force
por: Selfridge, J. M.
Publicado: (1897)

The Vital Force
por: Hawley, W. A.
Publicado: (1888)

Vital Force
por: Wells, P. P.
Publicado: (1884)

Vital Capacity
Publicado: (1863)

Vital Capacity
Publicado: (1867)

Vital Capacity
Publicado: (1878)

Vital Capacity
Publicado: (1873)

First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
por: Wuyts, Wim A., et al.
Publicado: (2016)

Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Biondini, Davide, et al.
Publicado: (2018)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Effects of forward head posture on forced vital capacity and respiratory muscles activity
por: Han, Jintae, et al.
Publicado: (2016)

Low forced vital capacity predicts poor prognosis in gastric cancer patients
por: Feng, Fan, et al.
Publicado: (2017)

“Poor Effort” Does Not Account for Reduced Forced Vital Capacity in Asthmatic Children
por: Feng, Yong, et al.
Publicado: (2021)

Reference Values of Forced Vital Capacity and Expiratory Flow in High-Level Cyclists
por: Dauty, Marc, et al.
Publicado: (2021)

Sarcoidosis beyond pulmonary involvement: A case series of unusual presentations
por: Medhat, Basma M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jom0sjte6c2ep44dfue0mieav2